Abstract: Composition for the skin, semi-mucous membranes and/or mucous membranes, comprising a polymer system capable of forming a film having a hardness of less than 50; and a make-up process and a non-therapeutic treatment process for the skin, semi-mucous membranes and/or mucous membranes, comprising applying a composition according to the invention thereto.
Abstract: The composition embodying the invention comprises an extract of chrysanthellum and at least one of the following list of compounds: a plant extract which is rich in phenolic compounds, a plant extract which is rich in carotenoids, a plant oil which is rich in tocopherols, an antioxidant of natural or synthetic origin and an enzymatic system for trapping free radicals, this composition exploiting synergistic radical-scavenging between the chrysanthellum and the compounds of this list.
Type:
Grant
Filed:
June 25, 1999
Date of Patent:
May 15, 2001
Assignee:
Lanatech Laboratoire Nature et Technique
Abstract: This invention relates to a method for topical treatment of human nail and skin diseases, including fungal infections, bacterial infections, and psoriatic infections. In addition, this invention relates to a method of treating the general condition of human nails including their strength, rate of growth and appearance. More particularly, the invention relates to an acidified composition and methods of using said composition. Still further the invention relates to an acidified lacquer useful in treating human nails and skin.
Type:
Grant
Filed:
March 9, 1999
Date of Patent:
May 15, 2001
Assignee:
Johnson & Johnson Consumer Companies, Inc.
Inventors:
Ying Sun, Jue-Chen Liu, Elizabeth Kimbleton, Jonas C. T. Wang
Abstract: The present invention provides greater than 99% pure bis(triorganosilyl)hydroxycarboxylates of the general formulae:
R3SiO—CHR1—COO—SiR3
R3SiO—CHR1—R2COO—SiR3
wherein each R is independently a monovalent straight or branched chain alkyl or alkenyl group having from 1 to about 6 carbon atoms, or an aryl group, R1 may be hydrogen, a monovalent straight or branched chain alkyl group having from 1 to about 18 carbon atoms, or an aryl group, and R2 is a divalent straight or branched chain alkyl group having from 1 to about 18 carbon atoms, an aryl group, or a straight or branched chain alkaryl group having from 7 to about 18 carbon atoms; a process for producing the bis(trimethylsilyl)hydroxycarboxylates comprising the trimethylsilylation with hexamethyldisilazane of the corresponding hydroxy carboxylic acids; cosmetic formulation comprising the greater than 99% pure bis(trimethylsilyl)hydroxycarboxylates dissolved in aprotic media; and a method of delivering hydroxycarboxyli
Abstract: Disclosed herein is a cosmetic composition comprising carbon dioxide gas, wherein the viscosity of the cosmetic composition is 100 to 500,000 mPa.s at 25° C., and the concentration of the carbon dioxide gas in the cosmetic composition ejected from the container is kept at 60 ppm or more for 15 minutes after the ejection. The cosmetic composition has the ability to retain carbon dioxide gas therein, can sustain a blood circulation-facilitating effect, has the effect of improving dull looking skin, dark circles and uneven skin tone, and gives users a pleasant feeling upon use.
Type:
Grant
Filed:
September 4, 1998
Date of Patent:
May 8, 2001
Assignee:
Kao Corporation
Inventors:
Hidenobu Takanabe, Atsuyuki Kiba, Kenji Kodama
Abstract: A method for treating natural fingernails and toenails and artificial fingernails and toenails includes the step of heating the fingernail or toenail to a temperature at which the material of the fingernail or toenail begins to melt. The forward edge of the nail can be fused and sealed by this method or the surface of the nail can be smoothed and polished. The device for treating natural fingernails and toenails and artificial fingernails and toenails has a heating unit for heating the fingernail or toenail.
Abstract: A therapeutic system for supplying active substances to the skin consists of a backing layer remote from the skin, with at least one active substance depot. The depot may consist of a fluid active substance or a fluid composition comprising an active substance delivery control matrix. There is also included an adhesive fixing device for fixing the therapeutic system on the skin. The therapeutic system is characterized in that the active substance depots (14) consist of at least one adjuvant having a supporting and distributing function by being provided with a planar textile material completely surrounded by matrix (12).
Type:
Grant
Filed:
March 9, 1998
Date of Patent:
May 1, 2001
Assignee:
LTS Lohmann Therapie-Systeme GmbH & Co. KG
Abstract: The compositions of the present invention are useful for the topical delivery of a wide variety of active ingredients. These compositions are particularly useful for treating conditions such as acne and its attendant skin lesions, blemishes, and other imperfections. These compositions are nonirritating to the skin and also provide skin feel benefits. These compositions can be in the form of leave-on products and products that are rinsed or wiped from the skin after use.
Abstract: The present invention relates to cosmetic compositions, comprising:
a.) from about 0.01% to about 50%, by weight, of vitamin B3 compound;
b.) from about 0% to about 90%, by weight, of an emollient component comprising from 0% to about 100%, by weight, of an oil liquid at ambient temperature;
c.) from about 0.01% to about 40%, by weight, of a polar solvent;
d.) from about 0% to about 90%, by weight, of a solidifying agent; and
e.) from about 0% to about 90%, on an anhydrous basis, of a color wherein the vitamin B3 compound is added to the composition such that the concentration of the vitamin B3 compound exceeds the saturation solubility of the vitamin B3 compound in the polar solvent.
Type:
Grant
Filed:
February 12, 1999
Date of Patent:
May 1, 2001
Assignee:
The Procter & Gamble Company
Inventors:
Michael Lee Vatter, David Edmund Tarantino, Nichole Marie Scherneck, Michael Gary Armstrong, Jr.
Abstract: A method of treating human skin including providing an impermeable patch having an adhesive on a side and a human skin treating composition containing an oxidizable element. A layer of the composition is applied to a portion of human skin and covered with the impermeable patch, whereby oxidation of the layer of the composition is retarded. The skin is smoothed of wrinkles prior to placement of the patch.
Type:
Grant
Filed:
September 3, 1998
Date of Patent:
April 24, 2001
Inventors:
Dan B. Pool, John T. Kreitzer, David F. Kreitzer
Abstract: This invention relates to the use of colloidal silicic acid as a cushioning agent in a composition including at least one film-forming material and at least one organic or aqueous solvent.
Type:
Grant
Filed:
June 19, 1997
Date of Patent:
April 24, 2001
Assignee:
L'Oreal
Inventors:
Roland Ramin, Béatrice Toumi, Colette Cazeneuve
Abstract: Direct compressed solid pharmaceutical dosage forms containing:
a) from about 40 to about 95% by weight acetaminophen;
b) from about 1 to about 60% by weight of a direct compression vehicle comprising microcrystalline cellulose; and
c) from about 0.01 to about 4.0% by weight of a pharmaceutically-acceptable lubricant are disclosed. The acetaminophen and direct compression vehicle are combined under high shear conditions which are sufficient to transform acetaminophen and direct compression vehicle into a homogenous granulate without degradation. In preferred aspects of the invention, the lubricant is also combined with the acetaminophen and direct compression vehicle under high shear conditions. Methods of preparing the directly compressed solid pharmaceutical dosage forms and methods of treatment with the dosage forms are also disclosed. The methods are particularly well suited for preparing directly compressed dosage forms containing high load (i.e.
Type:
Grant
Filed:
May 13, 1999
Date of Patent:
April 17, 2001
Assignee:
Edward Mendell Co., Inc.
Inventors:
Edward A. Hunter, Bob E. Sherwood, Joseph A. Zeleznik
Abstract: The invention concerns topical formulations such as nail varnishes comprising as the active agent the compound of formula I
in free base form or in acid addition salt form, together with a polymeric film former and further excipients as appropriate. It also concerns a process of preparation of such preparations by mixing with an appropriate polymeric film former and conventional further excipients as appropriate, and a method of treatment of onychomycosis.
Abstract: An active substance-containing transdermal pharmaceutical preparation with a given size of contact surface, comprising a tack-free backing layer which is permeable to active substances and an adhesive layer adhering to the skin is characterized by the fact that the backing layer comprises at least a third of the total active substance amount contained in the preparation.
Abstract: Provided are a composite powder comprising a core particle which is spherical and has a refractive index of from 1.40 to 1.60, and a coating component which is coated on the surface of the core particle in film form and has a refractive index of from 2.00 to 2.90, and a coloring composition containing the composite powder. The composite powder or coloring composition is coated on a coating surface to form a composite powder layer. The composite powder layer causes light interference to exhibit a color on the surface. The composite powder and coloring composition are used in various fields.
Abstract: Cosmetic varnish composition. At least one solvent, at least one nitrocellulose, at least one plasticizer, at least one resin, at least one otherwise unstable compound, preferably chosen from amino- and amido-functional compounds, and at least one stabilizer chosen from N-chlorosuccinimide and boric acid. The stabilizer is present in an amount effective to stabilize the at least one otherwise unstable compound. The composition is used for making nail varnish, make-up, or treatment varnish which is highly stable over time.
Abstract: A cosmetic which includes from about one to about ten parts ethyl cellulose, from about one to about ten parts of a cosmetic pigment, from about 70 to about 95 parts of an organic solvent, and from about one to about ten parts of an alcohol soluble and water insoluble resin. The resin is a polymer which includes one or more of the following monomers: octylacrylamide, acrylate, butylaminoethyl methacrylate, and methyl methacrylate, hydroxypropyl methacrylate, polyvinyl acetate.
Abstract: Sexual dysfunction in human females can be ameliorated, without substantial undesirable side effects, by apomorphine. Administration of apomorphine increases nerve stimulated clitoral intracavernosal blood flow and vaginal wall blood flow for enhanced clitoral erection and vaginal engorgement in a female. A plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter is preferably maintained.
Abstract: Embodiments include a liquid colorant composition having an acrylates/octylacrylamide copolymer, a cellulose material, alcohol and a colorant. The cellulose material may be hydroxypropylcellulose. Isostearyl alcohol and silica may be included in the composition to enhance properties such as the spreadability and feel of the composition on the lips. Additional additives such as fragrance and botanical extracts may also be added. Such compositions can be easily applied to the lips and offer long wear characteristics.